Literature DB >> 17086300

Complications and risk factors in transrectal ultrasound-guided prostate biopsies.

Carlos Márcio Nóbrega de Jesus1, Luiz Antônio Corrêa, Carlos Roberto Padovani.   

Abstract

CONTEXT AND
OBJECTIVE: Prostate biopsy is not a procedure without risk. There is concern about major complications and which antibiotics are best for routine use before these biopsies. The objective was to determine the rate of complications and the possible risk factors in prostate biopsies. DESIGN AND
SETTING: Prospective study, Faculdade de Medicina de Botucatu.
METHODS: Transrectal ultrasound (TRUS) guided prostate biopsies were carried out in 174 patients presenting either abnormality in digital rectal examinations (DRE) or levels higher than 4 ng/ml in prostate-specific antigen (PSA) tests, or both.
RESULTS: Hemorrhagic complications were the most common (75.3%), while infectious complications occurred in 19% of the cases. Hematuria was the most frequent type (56%). Urinary tract infection (UTI) occurred in 16 patients (9.2%). Sepsis was observed in three patients (1.7%). The presence of an indwelling catheter was a risk factor for infectious complications (p < 0.05). Higher numbers of biopsies correlated with hematuria, rectal bleeding and infectious complications (p < 0.05). The other conditions investigated did not correlate with post-biopsy complications.
CONCLUSIONS: Post-biopsy complications were mostly self-limiting. The rate of major complications was low, thus showing that TRUS guided prostate biopsy was safe and effective. Higher numbers of fragments taken in biopsies correlated with hematuria, rectal bleeding and infectious complications. An indwelling catheter represented a risk factor for infectious complications. The use of aspirin was not an absolute contraindication for TRUS.

Entities:  

Mesh:

Year:  2006        PMID: 17086300     DOI: 10.1590/s1516-31802006000400005

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  14 in total

1.  Variations in prostate biopsy practice: A quantitative questionnaire-based study.

Authors:  Matthew O Lipinski; D Robert Siemens; Patti A Groome
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

2.  Bacterial sepsis following prostatic biopsy.

Authors:  Luca Carmignani; Stefano Picozzi; Matteo Spinelli; Salvatore Di Pierro; Gabriella Mombelli; Ercole Negri; Milvana Tejada; Paola Gaia; Elena Costa; Augusto Maggioni
Journal:  Int Urol Nephrol       Date:  2012-02-28       Impact factor: 2.370

3.  Prostatic abscess after transrectal ultrasound-guided prostate biopsy. Case report.

Authors:  L Dell'atti
Journal:  G Chir       Date:  2013 Sep-Oct

4.  The effect of ultrasound-guided compression immediately after transrectal ultrasound-guided prostate biopsy on postbiopsy bleeding: a randomized controlled pilot study.

Authors:  Bong Hee Park; Jung Im Kim; Sang Rak Bae; Yong Seok Lee; Sung Hak Kang; Chang Hee Han
Journal:  Int Urol Nephrol       Date:  2017-05-04       Impact factor: 2.370

5.  Sedoanalgesia with midazolam and fentanyl citrate controls probe pain during prostate biopsy by transrectal ultrasound.

Authors:  Fábio Hissachi Tsuji; Renato Caretta Chambó; Aparecido Donizeti Agostinho; José Carlos Souza Trindade Filho; Carlos Márcio Nóbrega de Jesus
Journal:  Korean J Urol       Date:  2014-02-14

6.  Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy.

Authors:  Xue-Fei Ding; Yang Luan; Sheng-Ming Lu; Guang-Chen Zhou; Tian-Bao Huang; Liang-Yong Zhu; Cheng-Hao Guo
Journal:  World J Urol       Date:  2020-09-19       Impact factor: 4.226

7.  Morbidity and psychological impact of prostate biopsy: the future calls for a change.

Authors:  Andrea Minervini; Gianni Vittori; Giampaolo Siena; Marco Carini
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

8.  What is the ideal core number for ultrasound-guided prostate biopsy?

Authors:  Renato Caretta Chambó; Fábio Hissachi Tsuji; Flávio de Oliveira Lima; Hamilto Akihissa Yamamoto; Carlos Márcio Nóbrega de Jesus
Journal:  Korean J Urol       Date:  2014-11-04

9.  Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy.

Authors:  Renato Caretta Chambó; Fabio Hissachi Tsuji; Hamilton Akihissa Yamamoto; Carlos Marcio Nobrega de Jesus
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541

10.  Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.

Authors:  Athanasios Tsalatsanis; Iztok Hozo; Ambuj Kumar; Benjamin Djulbegovic
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.